1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Cato BioVentures

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Type

Private Equity Firm

Location

Durham NC US

Alternative Asset Classes

PE

Established

1990

Firm Ownership

Captive Arm – Corporate

Investment Team Staff

Total Staff

2
Founded in 1990, based in Durham, North Carolina. Cato BioVentures is a private equity and venture capital arm of Cato Research Ltd. and Cato Holding. The firm makes investments in all stages, focuses on biotechnology and pharmaceutical companies.
Asset Class No. of Funds Currently Managed Funds Raised in Last 10 Years Est. Dry Powder Strategies
Private Equity - Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Venture (General)
Real Estate - -
Private Debt - -
Infrastructure - -
Natural Resources - -
Asset Class No. of Funds Currently Managed AuM Date of AuM Strategies
Hedge Funds 0 -

Want to see more?

Request a demo for full access to this profile.

1 Known Decision Makers

Contact Name Position Location Email Telephone Asset Class
President Durham, US PE

Showing 1 of 1 known decision makers at Cato BioVentures

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.